ANDREA GLEZER

Scopus Publications

Disease activity and maternal–fetal outcomes in pregnant women with cushing’s syndrome: a systematic review and meta‑analysis
Diego Barata Bandeira, Gabriela de Abreu Santos, Andrea Glezer, Marcio Carlos Machado, Cesar Luiz Boguszewski, Vania dos Santos Nunes-Nogueira
Reviews in Endocrine and Metabolic Disorders, 2026
Pregnancy in women with Cushing’s syndrome (CS) is uncommon due to the detrimental effects of hypercortisolism on fertility and is associated with an increased risk of maternal and fetal complications. This systematic review evaluated the natural course and maternal–fetal outcomes of CS during pregnancy. Searches were conducted in MEDLINE, EMBASE and LILACS for observational studies including at least three pregnant women with CS. Twenty-two studies comprising 381 pregnancies were included. Among 200 women with reported etiologies, 54% had Cushing’s disease, 24% had adrenal adenoma, and 11% had adrenal carcinoma. The overall rate of spontaneous miscarriage was 6% (21 studies, 245 pregnancies; 95% CI, 3–13%), and that of preterm birth was 37% (18 studies, 342 pregnancies; 95% CI, 24–52%). Worsening of preexisting diabetes or development of gestational diabetes was reported in 24% (16 studies, 344 pregnancies; 95% CI, 13–39%), whereas hypertensive disorders of pregnancy (HDP) occurred in 39% (19 studies, 362 pregnancies; 95% CI, 23–58%). Among 134 pregnancies, only one thromboembolic event was reported. The perinatal mortality rate was 7% (18 studies, 342 newborns; 95% CI, 3–14%), low birth weight was 26% (11 studies, 113 newborns; 95% CI, 15–43%), and congenital malformations were 1% (11 studies, 306 newborns; 95% CI, 0–7%). A meta-analysis of four studies revealed that uncontrolled hypercortisolism was associated with higher odds of HDP, diabetes, and preterm birth. These findings suggest that pregnancy in women with uncontrolled CS is associated with an increased risk of adverse maternal and fetal outcomes.
Temozolomide in aggressive and metastatic pituitary tumors: a Brazilian multicenter real-world cohort study
Isabelle Pinheiro Amaro de Magalhães, Camila Regina Pereira Batista de Macedo, Luciana Ansaneli Naves, Mauro Antonio Czepielewski, Isabella Naves Rosa, Lidiana Bandeira de Santana, Tobias Skrebsky de Almeida, Mario Padula, Paula Condé Lamparelli Elias, Margaret de Castro, Leandro Kasuki, Monica Roberto Gadelha, Carolina Garcia Soares Leães Rech, Heraldo Mendes Garmes, Cesar Luiz Boguszewski, Raquel Soares Jallad, Marilena Nakaguma, Maria Candida Barisson Villares Fragoso, Marcio Carlos Machado, Andrea Glezer, Malebranche Berardo Carneiro da Cunha Neto, Olavo Feher, Rafael Loch Batista
Pituitary, 2026
To evaluate the real-world efficacy and safety of temozolomide (TMZ) in aggressive and metastatic pituitary neuroendocrine tumors in a Latin American setting, and to address whether TMZ achieves meaningful radiological and biochemical disease control with acceptable toxicity. We conducted a retrospective multicenter study across Brazilian reference centers including patients with aggressive/metastatic pituitary adenomas treated with TMZ and followed for ≥ 6 months. The radiological response was assessed via RECIST 1.1. For functioning pituitary adenomas, biochemical response was assessed using prespecified hormonal criteria. Adverse events were collected from medical records. Thirty patients were included (mean age 29.5 years; 53% female). All the tumors were macroadenomas, and 56% were giant (> 4 cm). Twenty-one pituitary adenomas were functioning and four were metastatic. Ki-67 was > 3% in 73% of the patients. The mean time from diagnosis to TMZ initiation was 102 months. The radiological disease control rate (partial response or stable disease) was 93.3%. Among functioning tumors, the biochemical disease control rate was 81.2%, with an objective biochemical response rate (complete + partial response) of 68.8%. Adverse events, most commonly nausea and myelotoxicity, occurred in 66% of patients. In this multicenter Brazilian real-world cohort, TMZ provided high radiological and biochemical disease control with an acceptable safety profile, suggesting that TMZ is the preferred first-line systemic chemotherapy for aggressive/metastatic pituitary adenomas after the failure of standard therapies.
Approach to the Patient With Dopamine-Resistant Microprolactinoma
Andrea Glezer, Matheo Augusto Morandi Stumpf, Nara Lima Queiroz
Journal of Clinical Endocrinology and Metabolism, 2026
Prolactinoma is a significant cause of hyperprolactinemia and the most common type of pituitary tumor. Women of fertile age are most commonly affected, and the clinical picture is characterized by galactorrhea, oligo-amenorrhea, and infertility. In microprolactinomas, which represent more than 60% of cases in women before menopause, there is usually no concern about the mass effect. Therefore, management can be expectant if there are no symptoms or in a patient in the postmenopausal period; oral contraceptive in the presence of hypogonadism and no desire for pregnancy; dopamine agonist (DA) in the presence of bothersome galactorrhea, hypogonadism, and the desire for fertility; and neurosurgery in selected noninvasive cases. Resistance to DA occurs in less than 10% of cases. Although the reduction in dopamine receptor subtype 2 expression is considered the primary cause of DA resistance, the underlying mechanisms are not yet completely elucidated. The main concern in resistant cases is the risk of symptomatic tumor growth during assisted reproduction techniques and pregnancy. Other conditions in which hyperprolactinemia could be implicated, such as metabolic parameters, osteoporosis, and breast cancer risk are also discussed. Understanding the mechanisms of DA resistance can lead to the opening of new treatment strategies.
Fertility and pregnancy in patients with prolactinoma
Matheo A.M. Stumpf, Nara L. Queiroz, Andrea Glezer
Best Practice and Research Clinical Endocrinology and Metabolism, 2026
Prevalence and Associated Risk Factors for Venous Thromboembolism in a Large Cohort of Patients With Cushing Disease
Ana Julia Garcia Pereira, Rafael Loch Batista, Malebranche Berardo Carneiro Cunha-Neto, Valter Angelo Sperling Cescato, Gilberto Ochman da Silva, Maria Candida Barisson Villares Fragoso, Ines Nobuko Nishimoto, Andrea Glezer, Marcio Carlos Machado
Endocrine Practice, 2026
Patient perceptions of pituitary incidentaloma diagnosis and follow-up: a Pituitary Society international patient survey
Hidenori Fukuoka, Andrea Glezer, Niki Karavitaki, Ann McCormack, Mark Gurnell, Yona Greenman, Fabienne Langlois, Theodore H. Schwartz, Shlomo Melmed, Maria Fleseriu
Pituitary, 2026
Neuroendocrine and nutritional disorders
Manoel Martins, Andrea Glezer, Carolina Garcia Soares Leães Rech, Synara Cavalcante Lopes Braga
Nutritional Neuroscience from Bench to Bedside, 2026
Results for LINAC-based radiosurgery or fractionated stereotactic radiotherapy for corticotropic pituitary tumors: a single-center retrospective cohort
Geovanne Pedro Mauro, Leila Maria Da Róz, Vinicius de Carvalho Gico, Eduardo Weltman, Evandro César de Souza, Andrea Glezer, Marcio Carlos Machado, Carlos Gilberto Carlotti, Rosangela Correa Villar
Journal of Endocrinological Investigation, 2025
Pituitary incidentaloma: a Pituitary Society international consensus guideline statement
Maria Fleseriu, Mark Gurnell, Ann McCormack, Hidenori Fukuoka, Andrea Glezer, Fabienne Langlois, Theodore H. Schwartz, Yona Greenman, Nidhi Agrawal, Amit Akirov, Irina Bancos, Cristina Capatina, Frederic Castinetti, Michael Catalino, Mirjam Christ-Crain, Liza Das, Andjela Drincic, Pamela U. Freda, Monica R. Gadelha, Andrea Giustina, Felicia Hanzu, Ken K. Y. Ho, Kristina Isand, Susana Mallea-Gil, Adam N. Mamelak, Hani J. Marcus, Meliha Melin Uygur, Mark Molitch, Lisa B. Nachtigall, Elisabeth Nowak, Alberto M. Pereira, Maria M. Pineyro, Ismat Shafiq, Luis Syro, Yutaka Takahashi, Elena V. Varlamov, Greisa Vila, Gabriel Zada, Niki Karavitaki, Shlomo Melmed, , , Theodore H. Schwartz, and
Nature Reviews Endocrinology, 2025
Ectopic GHRH production: revisiting a rare cause of acromegaly
Matheo A. M. Stumpf, Nathalie Oliveira Santana, Marcio Carlos Machado, Felipe H. Duarte, Andrea Glezer, Gérald Raverot, Véronique Raverot, Raquel S. Jallad
Reviews in Endocrine and Metabolic Disorders, 2025
Impulse control disorders in pituitary adenoma: What do we know and what we still don´t know in almost two decades?
P. Kadioglu, A. Glezer
Pituitary, 2025
Disease Activity and Maternal–fetal Outcomes in Pregnant Women With Prolactinoma: A Systematic Review and Meta-analysis
Diego Barata Bandeira, Letícia Santana Alves, Andrea Glezer, Cesar Luiz Boguszewski, Vania dos Santos Nunes-Nogueira
Journal of Clinical Endocrinology and Metabolism, 2025
Editorial: Advances and challenges in adult-onset craniopharyngioma
Odelia Cooper, Andrea Glezer, Thomas Cuny
Frontiers in Endocrinology, 2025
Pituitary Disorders during Pregnancy and Lactation
Maternal Fetal and Neonatal Endocrinology Physiology Pathophysiology and Clinical Management, 2025
Pituitary Physiology During Pregnancy and Lactation
Maternal Fetal and Neonatal Endocrinology Physiology Pathophysiology and Clinical Management, 2025
Expression of MMP-2, MMP-9 and TIMP-2 in pituitary tumors and their relationship with cavernous sinus invasion
Ane Caroline Thé B Freire, Raquel S Jallad, Rafael L Batista, Andrea Glezer, Marcio C Machado, Gilberto Ochman, Valter A Cescato, Malebranche Berardo Carneiro Cunha Neto, Fernando P Frassetto, Raphael S S de Medeiros, Ericka B Trarbach
Endocrine Oncology, 2025
Position statement on macroprolactinemia from the Department of Neuroendocrinology of the Brazilian Society of Endocrinology and Metabolism (SBEM) and the Brazilian Society of Clinical Pathology/Laboratory Medicine (SBPC/ML)
Andrea Glezer, Paula Condé Lamparelli Elias, Vania dos Santos Nunes Nogueira, Heraldo Mendes Garmes, Leandro Kasuki, Guilherme Alcides Flôres Soares Rollin, Manoel Ricardo Alves Martins, Adriana Caschera Leme, Pedro Saddi Rosa, Luciana Ansaneli Naves, Marcelo Cidade Batista
Archives of Endocrinology and Metabolism, 2025
A new and useful tool for differentiating prolactinomas from non-functioning pituitary adenomas: a pilot study of the cabergoline disconnection test
Stefano Alvarenga Galliano, Matheo Augusto Morandi Stumpf, Nara L. Queiroz, Eduardo Henrique Rodrigues Ferreira, Flora Ladeira Craveiro, Christiane Gruetzmacher, Gilberto Ochman da Silva, Valter Angelo Sperling Cescato, Eduardo Arnaldo Silva Vellutini, Malebranche Berardo Carneiro Cunha-Neto, Rafael Loch Batista, Andrea Glezer
Einstein Sao Paulo Brazil, 2025
Long-term use of clomiphene in male macroprolactinomas with persistent hypogonadism
Matheo A. M. Stumpf, Stefano A. Galliano, Cristina B. F. Bueno, Andrea Glezer
Endocrine, 2024
Aromatase inhibitors as a therapeutic strategy for male prolactinoma resistant to dopamine agonists: a retrospective cohort study and literature review
D. Zúñiga, M. A. M. Stumpf, A. L. S. Monteiro, A. Glezer
Journal of Endocrinological Investigation, 2024
Correction to: Aromatase inhibitors as a therapeutic strategy for male prolactinoma resistant to dopamine agonists: a retrospective cohort study and literature review (Journal of Endocrinological Investigation, (2023), 47, 5, (1295-1303), 10.1007/s40618-023-02231-z)
Diana Zúñiga, M. A. M. Stumpf, A. L. S. Monteiro, A. Glezer
Journal of Endocrinological Investigation, 2024
Treatment of hyperprolactinemia in women: A Position Statement from the Brazilian Federation of Gynecology and Obstetrics Associations (Febrasgo) and the Brazilian Society of Endocrinology and Metabolism (SBEM)
Cristina Laguna Benetti-Pinto, Andrea Prestes Nácul, Ana Carolina Japur de Sá Rosa-e-Silva, Gustavo Arantes Rosa Maciel, Vania dos Santos Nunes Nogueira, Paula Condé Lamparelli Elias, Manoel Martins, Leandro Kasuki, Heraldo Mendes Garmes, Andrea Glezer
Archives of Endocrinology and Metabolism, 2024
Hyperprolactinemia in women: diagnostic approach
Andrea Glezer, Heraldo Mendes Garmes, Leandro Kasuki, Manoel Martins, Paula Condé Lamparelli Elias, Vania dos Santos Nunes Nogueira, Ana Carolina Japur de Sá Rosa-e-Silva, Gustavo Arantes Rosa Maciel, Cristina Laguna Benetti-Pinto, Andrea Prestes Nácul
Revista Brasileira De Ginecologia E Obstetricia, 2024
Hyperprolactinemia in women: treatment
Cristina Laguna Benetti-Pinto, Andrea Prestes Nácul, Ana Carolina Japur Rosa e Silva, Gustavo Arantes Rosa Maciel, Vania dos Santos Nunes Nogueira, Paula Condé Lamparelli Elias, Manoel Martins, Leandro Kasuki, Heraldo Mendes Garmes, Andrea Glezer
Revista Brasileira De Ginecologia E Obstetricia, 2024
Diagnosis of hyperprolactinemia in women: A Position Statement from the Brazilian Federation of Gynecology and Obstetrics Associations (Febrasgo) and the Brazilian Society of Endocrinology and Metabolism (SBEM)
Andrea Glezer, Heraldo Mendes Garmes, Leandro Kasuki, Manoel Martins, Paula Condé Lamparelli Elias, Vania dos Santos Nunes Nogueira, Ana Carolina Japur de Sá Rosa-e-Silva, Gustavo Arantes Rosa Maciel, Cristina Laguna Benetti-Pinto, Andrea Prestes Nácul
Archives of Endocrinology and Metabolism, 2024
PRL-R Variants Are Not only Associated with Prolactinomas but Also with Dopamine Agonist Resistance
Andrea Ramos de Castro Moreira, Ericka Trarbach, Cristina Bellotti Formiga Bueno, Anna Louise Stellfeld Monteiro, Isabella Pacetti Pajaro Grande, Mario Padula, Gustavo Arantes Rosa Maciel, Andrea Glezer
Journal of Clinical Endocrinology and Metabolism, 2023
How to manage intolerance to dopamine agonist in patients with prolactinoma
Matheo Augusto Morandi Stumpf, Felipe Moura Maia Pinheiro, Gilberto Ochman Silva, Valter Angelo Sperling Cescato, Nina Rosa Castro Musolino, Malebranche Berardo Carneiro Cunha-Neto, Andrea Glezer
Pituitary, 2023
The interplay between prolactin and cardiovascular disease
Andrea Glezer, Mariana Ramos Santana, Marcello D. Bronstein, Jose Donato, Raquel Soares Jallad
Frontiers in Endocrinology, 2023
Prolactinomas and Disorders of Prolactin Secretion
Degroot S Endocrinology Basic Science and Clinical Practice, 2022
Hyperprolactinemia
Andrea Glezer, Marcello D. Bronstein
Endocrinology and Diabetes A Problem Oriented Approach Second Edition, 2022
The Pituitary Gland in Pregnancy
Andrea Glezer, Marcello D. Bronstein
Pituitary, 2022
Management of hypopituitarism: A perspective from the Brazilian society of endocrinology and metabolism
Heraldo Mendes Garmes, César Luiz Boguszewski, Paulo Augusto Carvalho Miranda, Manoel Ricardo Alves Martins, Silvia Regina Correa da Silva, Julio Zaki Abucham, Nina Rosa de Castro Musolino, Lucio Vilar, Luiz Henrique Corrêa Portari, Mônica Roberto Gadelha, Leandro Kasuki, Luciana Ansaneli Naves, Mauro Antônio Czepielewski, Tobias Skrebsky de Almeida, Felipe Henning Gaia Duarte, Andrea Glezer, Marcello Delano Bronstein
Archives of Endocrinology and Metabolism, 2021
Management of pituitary tumors in pregnancy
Andrea Glezer, Raquel S. Jallad, Marcio C. Machado, Marcello D. Bronstein
Pituitary Tumors A Comprehensive and Interdisciplinary Approach, 2021
A Brazilian multicentre study evaluating pregnancies induced by cabergoline in patients harboring prolactinomas
B. G. Sant’ Anna, N. R. C. Musolino, M. R. Gadelha, C. Marques, M. Castro, P. C. L. Elias, L. Vilar, R. Lyra, M. R. A. Martins, A. R. P. Quidute, J. Abucham, D. Nazato, H. M. Garmes, M. L. C. Fontana, C. L. Boguszewski, C. B. Bueno, M. A. Czepielewski, E. S. Portes, V. S. Nunes-Nogueira, A. Ribeiro-Oliveira, R. P. V. Francisco, M. D. Bronstein, A. Glezer
Pituitary, 2020
Prolactinomas in pregnancy: considerations before conception and during pregnancy
Andrea Glezer, Marcello D. Bronstein
Pituitary, 2020
Pituitary Physiology During Pregnancy and Lactation
Raquel Soares Jallad, Andrea Glezer, Marcio Carlos Machado, Marcello D. Bronstein
Maternal Fetal and Neonatal Endocrinology Physiology Pathophysiology and Clinical Management, 2020
Pituitary Disorders During Pregnancy and Lactation
Raquel Soares Jallad, Andrea Glezer, Marcio Carlos Machado, Marcello D. Bronstein
Maternal Fetal and Neonatal Endocrinology Physiology Pathophysiology and Clinical Management, 2020
Pituitary Disorders During Pregnancy and Lactation
Raquel Soares Jallad, Andrea Glezer, Marcio Carlos Machado, Marcello D. Bronstein
Maternal Fetal and Neonatal Endocrinology Physiology Pathophysiology and Clinical Management, 2019
Pituitary Physiology During Pregnancy and Lactation
Raquel Soares Jallad, Andrea Glezer, Marcio Carlos Machado, Marcello D. Bronstein
Maternal Fetal and Neonatal Endocrinology Physiology Pathophysiology and Clinical Management, 2019
Filamin A and DRD2 expression in corticotrophinomas
Thais Sickler, Ericka Barbosa Trarbach, Fernando Pereira Frassetto, Juliano Bertollo Dettoni, Venâncio Avancini Ferreira Alves, Maria Candida Barisson Villares Fragoso, Marcio Carlos Machado, Ellison Fernando Cardoso, Marcello Delano Bronstein, Andrea Glezer
Pituitary, 2019
Prolactin-Secreting Pituitary Adenomas: Pathology, Clinical Manifestations, and Diagnosis
Andrea Glezer, Marcello D. Bronstein
Contemporary Endocrinology, 2019
Prolactinomas: How to handle prior to and during pregnancy?
Andrea Glezer, Marcello D. Bronstein
Minerva Endocrinologica, 2018
Management of pituitary tumors during pregnancy and lactation
Andrea Glezer, Raquel S. Jallad, Marcio C. Machado, Maria Candida B.V. Fragoso, Marcello D. Bronstein
Current Opinion in Endocrine and Metabolic Research, 2018
Controversial issues in the management of hyperprolactinemia and prolactinomas – An overview by the neuroendocrinology department of the Brazilian society of endocrinology and metabolism
Lucio Vilar, Julio Abucham, José Luciano Albuquerque, Luiz Antônio Araujo, Monalisa F. Azevedo, Cesar Luiz Boguszewski, Luiz Augusto Casulari, Malebranche B. C. Cunha, Mauro A. Czepielewski, Felipe H. G. Duarte, Manuel dos S. Faria, Monica R. Gadelha, Heraldo M. Garmes, Andrea Glezer, Maria Helane Gurgel, Raquel S. Jallad, Manoel Martins, Paulo A. C. Miranda, Renan M. Montenegro, Nina R. C. Musolino, Luciana A. Naves, Antônio Ribeiro-Oliveira, Cíntia M. S. Silva, Camila Viecceli, Marcello D. Bronstein
Archives of Endocrinology and Metabolism, 2018
Apoplexy in nonfunctioning pituitary adenomas
Luiz Eduardo Wildemberg, Andrea Glezer, Marcello D. Bronstein, Mônica R. Gadelha
Pituitary, 2018
Cabergoline and prolactinomas: lack of association between DRD2 polymorphisms and response to treatment
CBF Bueno, EB Trarbach, MD Bronstein, A Glezer
Pituitary, 2017
The Pituitary Gland in Pregnancy
Andrea Glezer, Marcello D. Bronstein
Pituitary Fourth Edition, 2017
Pregnancy and pituitary adenomas
Minerva Endocrinologica, 2016
Giant prolactinomas larger than 60 mm in size: a cohort of massive and aggressive prolactin-secreting pituitary adenomas
Ilan Shimon, Ernesto Sosa, Victoria Mendoza, Yona Greenman, Amit Tirosh, Etual Espinosa, Vera Popovic, Andrea Glezer, Marcello D. Bronstein, Moises Mercado
Pituitary, 2016
Prolactinomas
Andrea Glezer, Marcello D. Bronstein
Endocrinology and Metabolism Clinics of North America, 2015
Pituitary apoplexy: Pathophysiology, diagnosis and management
Andrea Glezer, Marcello D. Bronstein
Archives of Endocrinology and Metabolism, 2015
Hyperprolactinemia
Andrea Glezer, Marcello D. Bronstein
Endocrinology and Diabetes A Problem Oriented Approach, 2014
Prolactinomas, cabergoline, and pregnancy
Andrea Glezer, Marcello D. Bronstein
Endocrine, 2014
Prolactinoma
Andrea Glezer, Marcello D. Bronstein
Arquivos Brasileiros De Endocrinologia E Metabologia, 2014
Penetrance of functioning and nonfunctioning pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1 in the second decade of life
Tatiana D. Gonçalves, Rodrigo A. Toledo, Tomoko Sekiya, Sergio E. Matuguma, Fauze Maluf Filho, Manoel S. Rocha, Sheila A. C. Siqueira, Andrea Glezer, Marcelo D. Bronstein, Maria A. A. Pereira, Ricardo Jureidini, Telesforo Bacchella, Marcel C. C. Machado, Sergio P. A. Toledo, Delmar M. Lourenço
Journal of Clinical Endocrinology and Metabolism, 2014
An intrasellar germinoma with normal tumor marker concentrations mimicking primary lymphocytic hypophysitis
Mariana F. Guzzo, Cristina B. Formiga Bueno, Thiago T. Amancio, Sergio Rosemberg, Cleonice Bueno, Edson L. Arioli, Andrea Glezer, Marcello D. Bronstein
Arquivos Brasileiros De Endocrinologia E Metabologia, 2013
Approach to the patient with persistent hyperprolactinemia and negative sellar imaging
Andrea Glezer, Marcello D. Bronstein
Journal of Clinical Endocrinology and Metabolism, 2012
Primary antiphospholipid syndrome and panhypopituitarism: A unique presentation
Acta Reumatologica Portuguesa, 2012
Heparin increases HLA-G levels in Primary Antiphospholipid Syndrome
Jozélio Freire de Carvalho, Ricardo M. de Oliveira, Carlos Ewerton Maia Rodrigues, Andréa Glezer, Eloísa Bonfá, Rosa Maria Rodrigues Pereira
Clinical and Developmental Immunology, 2012
Pituitary autoimmune disease: Nuances in clinical presentation
A. Glezer, M. D. Bronstein
Endocrine, 2012
Clinically nonfunctioning pituitary adenoma growth after radiosurgery
Rafael Loch Batista, Andrea Cecilia Toscanini, Andrea Glezer, Mário Gilberto Siqueira, Salomon Benabou, Erick Talamoni Fonoff, Wagner Malagó Tavares, Manoel Jacobsen Teixeira, Malebranche Berardo Carneiro da Cunha Neto
Arquivos De Neuro Psiquiatria, 2012
The prolactin role in systemic lupus erythematosus: Where we are
Andrea Glezer, Diane Belchior Paraiba, Jozélio Freire de Carvalho
Revista Brasileira De Reumatologia, 2009
Rare Sellar Lesions
Andrea Glezer, Diane Belchior Paraiba, Marcello Delano Bronstein
Endocrinology and Metabolism Clinics of North America, 2008
Diagnosis and management of hyperprolactinemia: Results of a Brazilian multicenter study with 1234 patients
L. Vilar, M. C. Freitas, L. A. Naves, L. A. Casulari, M. Azevedo, R. Montenegro, A. I. Barros, M. Faria, G. C. Nascimento, J. G. Lima, L. H. Nóbrega, T. P. Cruz, A. Mota, A. Ramos, A. Violante, A. Lamounier Filho, M. R. Gadelha, M. A. Czepielewski, A. Glezer, M. D. Bronstein
Journal of Endocrinological Investigation, 2008
Metabolic syndrome: identifying the risk factors.
Simão Augusto Lottenberg, Andrea Glezer, Luiz Alberto Turatti
Jornal De Pediatria, 2007
Physico-chemical and biological characterizations of two human prolactin analogs exhibiting controversial bioactivity, synthesized in Chinese hamster ovary (CHO) cells
C.R.J. Soares, A. Glezer, K. Okazaki, E.K.M. Ueda, S.R. Heller, A.M. Walker, V. Goffin, P. Bartolini
Protein Expression and Purification, 2006
Human macroprolactin displays low biological activity via its homologous receptor in a new sensitive bioassay
Andrea Glezer, Carlos R. J. Soares, José G. Vieira, Daniel Giannella-Neto, Maria Teresa C. P. Ribela, Vincent Goffin, Marcello D. Bronstein
Journal of Clinical Endocrinology and Metabolism, 2006
Pitfalls in pituitary diagnosis: Peculiarities of three cases
A. Glezer, C. B. D’Alva, L. R. Salgado, N. R. Musolino, P. Serafini, J. G. Vieira, M. D. Bronstein
Clinical Endocrinology, 2002

ANDREA GLEZER

RESEARCH, TEACHING, or OTHER INTERESTS

Scopus Publications